Biocryst Pharmaceuticals Inc

Ownership Transactions Reported by 21 Insiders

Symbol
BCRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
4505 Emperor Boulevard, Suite 200, Durham, NC

Insiders trading volume in the past year

Biocryst Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jon P. Stonehouse President & CEO, Director $11M Dec 19, 2024
Charles K. Gayer Chief Commercial Officer $3.13M Dec 19, 2024
Alane P. Barnes Chief Legal Officer $3.05M Dec 19, 2024
Helen M. Thackray Chief R&D Officer $2.83M Mar 31, 2025
Anthony Doyle Chief Financial Officer $2.79M Dec 19, 2024
Yarlagadda S. Babu Chief Discovery Officer $1.81M Nov 14, 2022
Babar Ghias CFO & Head of Corp Development $1.52M Jul 24, 2025
Nancy J. Hutson Director $1.03M -$52.8K -4.9% Jun 12, 2025
Vincent Milano Director $752K Aug 29, 2025
Steven K. Galson Director $733K Jun 12, 2025
Alan G. Levin Director $665K Jun 12, 2025
Robert Alexander Ingram Director $606K Feb 28, 2023
Theresa Heggie Director $556K -$596K -51.7% Aug 13, 2025
Steve Aselage Director $469K Jun 12, 2024
Kenneth B. Lee Jr Director $417K Jun 13, 2023
Amy E. McKee Director $341K Aug 29, 2025
George B. Abercrombie Director $235K Jun 12, 2024
William P. Sheridan Chief Medical Officer $230K Mar 10, 2022
Machelle Sanders Director $219K -$68.5K -23.9% Nov 13, 2025
Steven Frank Director $133K Aug 29, 2025
Michael L. Jones Exec. Director, Finance - PAO $101K Dec 19, 2022

Recent Insider Transactions by Companies or Individuals for Biocryst Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.